PO:07:096 | Safety of filgotinib in the treatment of rheumatoid arthritis: results from the multicentre SOFIA study
Background. To evaluate safety of filgotinib in terms of frequency, severity, and type of adverse events (AEs) and to identify predictors of AEs in a multicentre cohort of patients with rheumatoid arthritis (RA). Materials and Methods. This is a prospective multicentre study that included pat...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
PAGEPress Publications
2025-11-01
|
| Edice: | Reumatismo |
| Témata: | |
| On-line přístup: | https://www.reumatismo.org/reuma/article/view/2136 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|